Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Is Rep 529 real-time PCR suitable for diagnosis of toxoplasmosis in patients infected with non-type II strains in Northern America?

Pomares C, Estran R, Press CJ, Bera A, Ramirez R, Montoya JG, Robert Gangneux F.

J Clin Microbiol. 2019 Nov 6. pii: JCM.01223-19. doi: 10.1128/JCM.01223-19. [Epub ahead of print]

PMID:
31694976
2.

Real-time PCR for diagnosis of imported schistosomiasis.

Guegan H, Fillaux J, Charpentier E, Robert-Gangneux F, Chauvin P, Guemas E, Boissier J, Valentin A, Cassaing S, Gangneux JP, Berry A, Iriart X.

PLoS Negl Trop Dis. 2019 Sep 11;13(9):e0007711. doi: 10.1371/journal.pntd.0007711. eCollection 2019 Sep.

3.

Dibothriocephalus nihonkaiensis: an emerging concern in western countries?

Robert-Gangneux F, Autier B, Gangneux JP.

Expert Rev Anti Infect Ther. 2019 Sep;17(9):677-679. doi: 10.1080/14787210.2019.1665028. Epub 2019 Sep 9. No abstract available.

PMID:
31498709
4.

A 37-Year-Old Woman With Left Sensomotor Seizure.

Belaz S, Chiforeanu D, Devaux JM, Tattevin P, Robert-Gangneux F, Gangneux JP.

Brain Pathol. 2019 Jul;29(4):577-578. doi: 10.1111/bpa.12751. No abstract available.

PMID:
31290229
5.

Serological and molecular screening of umbilical cord blood for Toxoplasma gondii infection; a reply to Botein et al.

Robert-Gangneux F, Djurković-Djaković O.

Transpl Infect Dis. 2019 Aug;21(4):e13127. doi: 10.1111/tid.13127. Epub 2019 Jun 18. No abstract available.

PMID:
31179601
6.

Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts' consensus recommendations.

Bongomin F, Govender NP, Chakrabarti A, Robert-Gangneux F, Boulware DR, Zafar A, Oladele RO, Richardson MD, Gangneux JP, Alastruey-Izquierdo A, Bazira J, Boyles TH, Sarcarlal J, Nacher M, Obayashi T, Worodria W, Pasqualotto AC, Meya DB, Cheng B, Sriruttan C, Muzoora C, Kambugu A, Rodriguez Tudela JL, Jordan A, Chiller TM, Denning DW.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1581-1584. doi: 10.1007/s10096-019-03600-4. No abstract available.

PMID:
31175479
7.

Dibothriocephalus nihonkaiensis: an emerging foodborne parasite in Brittany (France)?

Autier B, Belaz S, Degeilh B, Gangneux JP, Robert-Gangneux F.

Parasit Vectors. 2019 May 28;12(1):267. doi: 10.1186/s13071-019-3516-6.

8.

Molecular diagnosis of Pneumocystis pneumonia in immunocompromised patients.

Guegan H, Robert-Gangneux F.

Curr Opin Infect Dis. 2019 Aug;32(4):314-321. doi: 10.1097/QCO.0000000000000559.

PMID:
31107250
9.

Comparison of three commercial multiplex PCR assays for the diagnosis of intestinal protozoa.

Autier B, Belaz S, Razakandrainibe R, Gangneux JP, Robert-Gangneux F.

Parasite. 2018;25:48. doi: 10.1051/parasite/2018049. Epub 2018 Sep 18.

10.

Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.

Robert-Gangneux F, Meroni V, Dupont D, Botterel F, Garcia JMA, Brenier-Pinchart MP, Accoceberry I, Akan H, Abbate I, Boggian K, Bruschi F, Carratalà J, David M, Drgona L, Djurković-Djaković O, Farinas MC, Genco F, Gkrania-Klotsas E, Groll AH, Guy E, Hirzel C, Khanna N, Kurt Ö, Junie LM, Lazzarotto T, Len O, Mueller NJ, Munoz P, Pana ZD, Roilides E, Stajner T, van Delden C, Villena I, Pelloux H, Manuel O.

Emerg Infect Dis. 2018 Aug;24(8):1497-1504. doi: 10.3201/eid2408.180045.

11.

Performance of Molecular Approaches for Aspergillus Detection and Azole Resistance Surveillance in Cystic Fibrosis.

Guegan H, Chevrier S, Belleguic C, Deneuville E, Robert-Gangneux F, Gangneux JP.

Front Microbiol. 2018 Mar 27;9:531. doi: 10.3389/fmicb.2018.00531. eCollection 2018.

12.

The liver as an organ at risk for Toxoplasma transmission during transplantation: myth or reality?

Autier B, Dion S, Robert-Gangneux F.

J Clin Pathol. 2018 Sep;71(9):763-766. doi: 10.1136/jclinpath-2018-205066. Epub 2018 Mar 13.

13.

Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays.

Guegan H, Robert-Gangneux F, Camus C, Belaz S, Marchand T, Baldeyrou M, Gangneux JP.

J Infect. 2018 Feb;76(2):196-205. doi: 10.1016/j.jinf.2017.11.011. Epub 2017 Dec 14.

14.

Pneumocystis jirovecii and Cystic Fibrosis in Brittany, France.

Nevez G, Robert-Gangneux F, Pougnet L, Virmaux M, Belleguic C, Deneuville E, Rault G, Chevrier S, Ramel S, Le Bihan J, Guillaud-Saumur T, Calderon E, Le Govic Y, Gangneux JP, Le Gal S.

Mycopathologia. 2018 Feb;183(1):81-87. doi: 10.1007/s11046-017-0172-2. Epub 2017 Jul 7.

PMID:
28688008
15.

Evaluation of Toxoplasma ELITe MGB Real-Time PCR Assay for Diagnosis of Toxoplasmosis.

Robert-Gangneux F, Brenier-Pinchart MP, Yera H, Belaz S, Varlet-Marie E, Bastien P; Molecular Biology Study Group of the French National Reference Center for Toxoplasmosis.

J Clin Microbiol. 2017 May;55(5):1369-1376. doi: 10.1128/JCM.02379-16. Epub 2017 Feb 15.

16.

Epidemiology of Trichophyton verrucosum infection in Rennes University Hospital, France: A 12-year retrospective study.

Courtellemont L, Chevrier S, Degeilh B, Belaz S, Gangneux JP, Robert-Gangneux F.

Med Mycol. 2017 Oct 1;55(7):720-724. doi: 10.1093/mmy/myw142.

17.

Comparison of Leishmania typing results obtained from 16 European clinical laboratories in 2014.

Van der Auwera G, Bart A, Chicharro C, Cortes S, Davidsson L, Di Muccio T, Dujardin JC, Felger I, Paglia MG, Grimm F, Harms G, Jaffe CL, Manser M, Ravel C, Robert-Gangneux F, Roelfsema J, Töz S, Verweij JJ, Chiodini PL.

Euro Surveill. 2016 Dec 8;21(49). pii: 30418. doi: 10.2807/1560-7917.ES.2016.21.49.30418.

18.

Synthesis and biological properties of galactofuranosyl-containing fluorescent dyes.

Legentil L, Belaz S, Gangneux JP, Robert-Gangneux F, Ferrières V.

Bioorg Med Chem Lett. 2017 Jan 15;27(2):152-155. doi: 10.1016/j.bmcl.2016.11.090. Epub 2016 Dec 1.

19.

A misleading false-negative result of Pneumocystis real-time PCR assay due to a rare punctual mutation: A French multicenter study.

Le Gal S, Robert-Gangneux F, Pépino Y, Belaz S, Damiani C, Guéguen P, Pitous M, Virmaux M, Lissillour E, Pougnet L, Guillaud-Saumur T, Toubas D, Valot S, Hennequin C, Morio F, Hasseine L, Bouchara JP, Totet A, Nevez G.

Med Mycol. 2017 Feb 1;55(2):180-184. doi: 10.1093/mmy/myw051. Epub 2016 Aug 3.

PMID:
27489302
20.

Contribution of molecular tools for the diagnosis and epidemiology of fungal chronic rhinosinusitis.

Comacle P, Belaz S, Jegoux F, Ruaux C, Le Gall F, Gangneux JP, Robert-Gangneux F.

Med Mycol. 2016 Nov 1;54(8):794-800. doi: 10.1093/mmy/myw041. Epub 2016 Jun 22.

21.

Molecular diagnosis of toxoplasmosis in immunocompromised patients.

Robert-Gangneux F, Belaz S.

Curr Opin Infect Dis. 2016 Aug;29(4):330-9. doi: 10.1097/QCO.0000000000000275. Review.

PMID:
27191201
22.

[Pneumocystosis in non-HIV-infected immunocompromised patients].

Fillâtre P, Revest M, Belaz S, Robert-Gangneux F, Zahar JR, Roblot F, Tattevin P.

Rev Med Interne. 2016 May;37(5):327-36. doi: 10.1016/j.revmed.2015.10.002. Epub 2015 Nov 28. Review. French.

23.

Identification, biochemical characterization, and in-vivo expression of the intracellular invertase BfrA from the pathogenic parasite Leishmania major.

Belaz S, Rattier T, Lafite P, Moreau P, Routier FH, Robert-Gangneux F, Gangneux JP, Daniellou R.

Carbohydr Res. 2015 Oct 13;415:31-8. doi: 10.1016/j.carres.2015.07.001. Epub 2015 Jul 26.

PMID:
26279524
24.

Leishmania cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugates.

Cabezas Y, Legentil L, Robert-Gangneux F, Daligault F, Belaz S, Nugier-Chauvin C, Tranchimand S, Tellier C, Gangneux JP, Ferrières V.

Org Biomol Chem. 2015 Aug 21;13(31):8393-404. doi: 10.1039/c5ob00563a. Review.

PMID:
26130402
25.

Presence of Leishmania RNA Virus 1 in Leishmania guyanensis Increases the Risk of First-Line Treatment Failure and Symptomatic Relapse.

Bourreau E, Ginouves M, Prévot G, Hartley MA, Gangneux JP, Robert-Gangneux F, Dufour J, Sainte-Marie D, Bertolotti A, Pratlong F, Martin R, Schütz F, Couppié P, Fasel N, Ronet C.

J Infect Dis. 2016 Jan 1;213(1):105-11. doi: 10.1093/infdis/jiv355. Epub 2015 Jun 29.

PMID:
26123564
26.

Tungiasis Outbreak in Travelers From Madagascar.

Belaz S, Gay E, Robert-Gangneux F, Beaucournu JC, Guiguen C.

J Travel Med. 2015 Jul-Aug;22(4):263-6. doi: 10.1111/jtm.12217. Epub 2015 Jun 2.

27.

High negative predictive value diagnostic strategies for the reevaluation of early antifungal treatment: A multicenter prospective trial in patients at risk for invasive fungal infections.

Hasseine L, Cassaing S, Robert-Gangneux F, Fillaux J, Marty P, Gangneux JP; PF-qPCR Study Group.

J Infect. 2015 Aug;71(2):258-65. doi: 10.1016/j.jinf.2015.04.005. Epub 2015 Apr 18.

PMID:
25896093
28.

Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study.

Robert-Gangneux F, Sterkers Y, Yera H, Accoceberry I, Menotti J, Cassaing S, Brenier-Pinchart MP, Hennequin C, Delhaes L, Bonhomme J, Villena I, Scherer E, Dalle F, Touafek F, Filisetti D, Varlet-Marie E, Pelloux H, Bastien P.

J Clin Microbiol. 2015 May;53(5):1677-84. doi: 10.1128/JCM.03282-14. Epub 2015 Mar 11.

29.

Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.

Rostan O, Arshad MI, Piquet-Pellorce C, Robert-Gangneux F, Gangneux JP, Samson M.

Infect Immun. 2015 May;83(5):1738-48. doi: 10.1128/IAI.02908-14. Epub 2015 Feb 23. Review.

30.

A 10-year retrospective comparison of two target sequences, REP-529 and B1, for Toxoplasma gondii detection by quantitative PCR.

Belaz S, Gangneux JP, Dupretz P, Guiguen C, Robert-Gangneux F.

J Clin Microbiol. 2015 Apr;53(4):1294-300. doi: 10.1128/JCM.02900-14. Epub 2015 Feb 4.

31.

Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients.

Fillatre P, Decaux O, Jouneau S, Revest M, Gacouin A, Robert-Gangneux F, Fresnel A, Guiguen C, Le Tulzo Y, Jégo P, Tattevin P.

Am J Med. 2014 Dec;127(12):1242.e11-7. doi: 10.1016/j.amjmed.2014.07.010. Epub 2014 Jul 21.

32.

Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.

Robert-Gangneux F, Belaz S, Revest M, Tattevin P, Jouneau S, Decaux O, Chevrier S, Le Tulzo Y, Gangneux JP.

J Clin Microbiol. 2014 Sep;52(9):3370-6. doi: 10.1128/JCM.01480-14. Epub 2014 Jul 9.

33.

Alkyl galactofuranosides strongly interact with Leishmania donovani membrane and provide antileishmanial activity.

Suleman M, Gangneux JP, Legentil L, Belaz S, Cabezas Y, Manuel C, Dureau R, Sergent O, Burel A, Daligault F, Ferrières V, Robert-Gangneux F.

Antimicrob Agents Chemother. 2014;58(4):2156-66. doi: 10.1128/AAC.01350-13. Epub 2014 Jan 27.

34.

It is not only the cat that did it: how to prevent and treat congenital toxoplasmosis.

Robert-Gangneux F.

J Infect. 2014 Jan;68 Suppl 1:S125-33. doi: 10.1016/j.jinf.2013.09.023. Epub 2013 Oct 9. Review.

35.

The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.

Rostan O, Gangneux JP, Piquet-Pellorce C, Manuel C, McKenzie AN, Guiguen C, Samson M, Robert-Gangneux F.

MBio. 2013 Sep 17;4(5):e00383-13. doi: 10.1128/mBio.00383-13.

36.

Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

Fricker-Hidalgo H, Cimon B, Chemla C, Darde ML, Delhaes L, L'ollivier C, Godineau N, Houze S, Paris L, Quinio D, Robert-Gangneux F, Villard O, Villena I, Candolfi E, Pelloux H.

J Clin Microbiol. 2013 Jul;51(7):2103-11. doi: 10.1128/JCM.00169-13. Epub 2013 Apr 24.

37.

Absence of Pneumocystis dihydropteroate synthase mutants in Brittany, France.

Le Gal S, Robert-Gangneux F, Perrot M, Rouillé A, Virmaux M, Damiani C, Totet A, Gangneux JP, Nevez G.

Diagn Microbiol Infect Dis. 2013 May;76(1):113-5. doi: 10.1016/j.diagmicrobio.2013.01.018. Epub 2013 Feb 20.

PMID:
23433532
38.

Indoleamine 2,3-dioxygenase activity as a potential biomarker of immune suppression during visceral leishmaniasis.

Gangneux JP, Poinsignon Y, Donaghy L, Amiot L, Tarte K, Mary C, Robert-Gangneux F.

Innate Immun. 2013 Dec;19(6):564-8. doi: 10.1177/1753425912473170. Epub 2013 Feb 14.

PMID:
23413147
39.

Human hepatic stellate cells in primary culture are safe targets for Leishmania donovani.

Rostan O, Robert-Gangneux F, Lambert M, Samson M, Gangneux JP.

Parasitology. 2013 Apr;140(4):471-81. doi: 10.1017/S0031182012001965. Epub 2012 Dec 20.

PMID:
23253952
40.

Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia.

Fillatre P, Chevrier S, Revest M, Gacouin A, Jouneau S, Leroy H, Robert-Gangneux F, Minjolle S, Le Tulzo Y, Tattevin P.

Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):189-94. doi: 10.1007/s10096-012-1730-7. Epub 2012 Aug 22.

PMID:
22930407
41.

Epidemiology of and diagnostic strategies for toxoplasmosis.

Robert-Gangneux F, Dardé ML.

Clin Microbiol Rev. 2012 Apr;25(2):264-96. doi: 10.1128/CMR.05013-11. Review. Erratum in: Clin Microbiol Rev. 2012 Jul;25(3):583.

42.

Invariant NKT cells drive hepatic cytokinic microenvironment favoring efficient granuloma formation and early control of Leishmania donovani infection.

Robert-Gangneux F, Drogoul AS, Rostan O, Piquet-Pellorce C, Cayon J, Lisbonne M, Herbelin A, Gascan H, Guiguen C, Samson M, Gangneux JP.

PLoS One. 2012;7(3):e33413. doi: 10.1371/journal.pone.0033413. Epub 2012 Mar 22.

43.

The placenta: a main role in congenital toxoplasmosis?

Robert-Gangneux F, Murat JB, Fricker-Hidalgo H, Brenier-Pinchart MP, Gangneux JP, Pelloux H.

Trends Parasitol. 2011 Dec;27(12):530-6. doi: 10.1016/j.pt.2011.09.005. Epub 2011 Nov 11.

PMID:
22079164
44.

High level of soluble HLA-G in amniotic fluid is correlated with congenital transmission of Toxoplasma gondii.

Robert-Gangneux F, Gangneux JP, Vu N, Jaillard S, Guiguen C, Amiot L.

Clin Immunol. 2011 Feb;138(2):129-34. doi: 10.1016/j.clim.2010.12.004. Epub 2010 Dec 24.

PMID:
21185786
45.

Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis.

Patrat-Delon S, Gangneux JP, Lavoué S, Lelong B, Guiguen C, le Tulzo Y, Robert-Gangneux F.

J Clin Microbiol. 2010 Jul;48(7):2541-5. doi: 10.1128/JCM.00252-10. Epub 2010 May 12.

46.

Synthetic UDP-furanoses inhibit the growth of the parasite Leishmania.

Dureau R, Robert-Gangneux F, Gangneux JP, Nugier-Chauvin C, Legentil L, Daniellou R, Ferrières V.

Carbohydr Res. 2010 Jul 2;345(10):1299-305. doi: 10.1016/j.carres.2010.02.020. Epub 2010 Feb 24.

PMID:
20303072
47.

Clinical relevance of placenta examination for the diagnosis of congenital toxoplasmosis.

Robert-Gangneux F, Dupretz P, Yvenou C, Quinio D, Poulain P, Guiguen C, Gangneux JP.

Pediatr Infect Dis J. 2010 Jan;29(1):33-8. doi: 10.1097/INF.0b013e3181b20ed1.

PMID:
19858771
48.

Evaluation of DPC immulite 2000 Toxoplasma quantitative IgG/IgM kits for automated toxoplasmosis serology with immulite 2000.

Robert-Gangneux F, Bourhis C, Chevrier S, Gangneux JP.

J Clin Lab Anal. 2009;23(5):336-40. doi: 10.1002/jcla.20338.

PMID:
19774623
49.

Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection.

Robert-Gangneux F, Yera H, D'Herve D, Guiguen C.

Pediatr Infect Dis J. 2009 Jul;28(7):660-1. doi: 10.1097/INF.0b013e3181966020.

PMID:
19561432
50.

Serologic screening for Neospora caninum, France.

Robert-Gangneux F, Klein F.

Emerg Infect Dis. 2009 Jun;15(6):987-9. doi: 10.3201/eid1506.081414. No abstract available.

Supplemental Content

Loading ...
Support Center